- 专利标题： Anti-IL-36R antibodies for the treatment of pyoderma gangrenosum
-
申请号： US17376233申请日： 2021-07-15
-
公开(公告)号： US12098207B2公开(公告)日： 2024-09-24
- 发明人: Jay Fine , Janine Lamar , Steven John Padula , Meera Ramanujam , Sudha Visvanathan
- 申请人： Boehringer Ingelheim International GmbH
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim am Rhein
- 代理商 Wendy M. Gombert
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; A61K39/395 ; A61P17/00 ; A61K39/00
摘要：
The present invention provides methods for treating, preventing or ameliorating a neutrophilic dermatosis. The methods of the present invention include administering to a patient suffering from a neutrophilic dermatosis a pharmaceutical composition including an anti-interleukin-36 receptor (anti-IL-36R) antibody.
公开/授权文献
信息查询
